WO2022075105A1 - Asthma symptom management system and clothing provided with asthma symptom management system - Google Patents
Asthma symptom management system and clothing provided with asthma symptom management system Download PDFInfo
- Publication number
- WO2022075105A1 WO2022075105A1 PCT/JP2021/035321 JP2021035321W WO2022075105A1 WO 2022075105 A1 WO2022075105 A1 WO 2022075105A1 JP 2021035321 W JP2021035321 W JP 2021035321W WO 2022075105 A1 WO2022075105 A1 WO 2022075105A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- predetermined period
- average
- specific information
- heartbeat
- information
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title claims abstract description 137
- 208000024891 symptom Diseases 0.000 title claims abstract description 90
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 93
- 230000003187 abdominal effect Effects 0.000 claims description 70
- 230000001121 heart beat frequency Effects 0.000 claims description 19
- 230000000241 respiratory effect Effects 0.000 claims description 14
- 230000035565 breathing frequency Effects 0.000 claims description 12
- 230000036391 respiratory frequency Effects 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 description 29
- 230000010365 information processing Effects 0.000 description 25
- 230000007547 defect Effects 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 239000003990 capacitor Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 230000008054 signal transmission Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 230000008447 perception Effects 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000036387 respiratory rate Effects 0.000 description 4
- 230000000284 resting effect Effects 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 102000013691 Interleukin-17 Human genes 0.000 description 2
- 108050003558 Interleukin-17 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000003489 abdominal muscle Anatomy 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000005279 Status Asthmaticus Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/0245—Detecting, measuring or recording pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/113—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing
Definitions
- the present invention relates to an asthma symptom management system and clothing provided with an asthma symptom management system.
- Patent Document 1 includes a step of measuring a biomarker in a blood sample of an asthma patient and a step of determining the possibility of a severe attack of an asthma patient based on the measured value of the biomarker. Discloses methods that help predict the likelihood of severe seizures in asthmatic patients, including interleukin-17 (IL-17).
- IL-17 interleukin-17
- a specific information generator including a signal receiving unit capable of receiving a signal by wire and the specific information generating unit is provided, and the specific information generator is connected to the information processing device [22] to The asthma symptom management system according to any one of [24].
- Symptom management system. [28]
- the asthma according to any one of [22] to [27] which comprises a chest circumference measuring device including the chest circumference measuring section, and the chest circumference measuring device is connected to the information processing device.
- Symptom management system. Clothing provided with the asthma symptom management system according to any one of [1] to [28].
- Equations (1) and (2) compare the current biological information of the living body with the biological information one minute or more ago to determine whether or not the living body has a sign of an asthma attack or a mild asthma attack. It is an index. Since the biometric information of a sign of asthma attack or a mild attack of asthma fluctuates more slowly than that of a severe attack, there is little difference in fluctuation even when comparing the biometric information of adjacent predetermined periods, and it is difficult to discriminate the sign of the attack. On the other hand, it is possible to easily determine the sign of a seizure or the like by comparing with the biological information one minute or more ago. Therefore, the time interval between the end point of the first predetermined period and the start point of the second predetermined period is preferably 2 minutes or more, more preferably 5 minutes or more. On the other hand, the upper limit of the time interval is not particularly limited, but may be 72 hours or less, or may be 1 hour or less.
- the specific information generation unit 30 is controlled so as to generate the specific information S1 when the above equation (1) or equation (2) is satisfied. Further, in the specific information generation unit 30, either the average value of the breathing frequency and the average value of the heartbeat frequency satisfy the equation (1), or the average value of the breathing interval and the average value of the heartbeat interval are the equations (2), respectively. ) Satisfying the above conditions, it is more preferable that the specific information S1 is controlled to be generated.
- both the average value of the frequency of respiration and the average value of the frequency of heartbeat are used in calculating the formula (1), it is preferable to independently apply the average value to the formula (1) for calculation. In this case, each B1 may have a different value, and each B2 may have a different value.
- the average value of the frequency of respiration is, for example, the average of the time intervals between the peaks of the waveform related to the change in impedance in a predetermined period, and the time in the predetermined period divided by the average time interval to obtain the respiratory rate in the predetermined period ( It can be calculated by calculating the number of breaths (times) and dividing the respiratory rate (times) by the time (minutes, etc.) of a predetermined period.
- the frequency of breathing (times / minute, etc.) per n predetermined times for example, 1 minute
- the average value of the frequency of n breaths times / minute, etc.
- n is an integer of 1 or more.
- C1 in the formula (1) is preferably 2 seconds to 9 seconds, more preferably 3 seconds to 7 seconds, and 4 seconds to 6 seconds. Is even more preferable.
- C1 is the average value of the heartbeat intervals, C1 is preferably 500 msec to 1000 msec, more preferably 600 msec to 920 msec, and further preferably 650 msec to 860 msec. ..
- C2 has the same meaning as described above, and C3 is the average value of the breathing and / or heartbeat intervals in the third predetermined period starting from the time point after the end point of the second predetermined period.
- C3 is the mean value of the breathing interval
- C2 is the mean value of the heartbeat interval
- C3 is the mean value of the heartbeat interval.
- the above formula (6) determines that the rate of change in the average abdominal circumference is larger than the rate of change in the average chest circumference as compared with the sign of an asthma attack in the living body or the occurrence of a mild asthma attack. It is an index to do. That is, it is an index for discriminating that the living body is correctly performing abdominal breathing, and the accuracy of discriminating abdominal breathing is improved by the equation (6).
- the asthma symptom management system 1 is controlled to satisfy the above equations (5) and / or the above equations (6) in addition to the above equations (3) and / or the above equations (4) before generating the specific information S2. It is preferable that the specific information S2 is controlled to be generated after satisfying the above formulas (5) and (6) in addition to the above formula (3) or the above formula (4).
- Asthma symptom management system 1 preferably has an information processing unit 20 as shown in FIG.
- the information processing unit 20 preferably includes an information receiving unit 21, a calculation unit 24, a storage unit 25, and a signal transmitting unit 26.
- the information obtained from the biometric information acquisition unit 10 is transmitted to, for example, the information receiving unit 21 of the information processing unit 20, and then the biometric information via the calculation unit 24, the storage unit 25, and the like.
- the signal is transmitted from the signal transmission unit 26 to the specific information generation unit 30 if the predetermined requirements such as the above equation (1) are satisfied.
- the living body information acquisition unit 10 of the asthma symptom management system 1 is brought into contact with the living body to start acquisition of the living body information.
- the biometric information obtained from the biometric information acquisition unit 10 is transmitted to the information receiving unit 21 of the information processing unit 20, and then transmitted to the arithmetic unit 24.
- the calculation unit 24 calculates the average value A1 of the heartbeat frequency per predetermined period, and the value is stored in the storage unit 25 as the average value of the heartbeat frequency in the first predetermined period.
- a part or all of the biological information obtained from the biological information acquisition unit 10 in the first predetermined period may be transmitted to the storage unit 25 and stored, and the calculation unit 24 may store the stored information.
- the average value A1 of the frequency of heartbeats may be calculated.
- biometric information obtained from the biometric information acquisition unit 10 in the third predetermined period may be partially or wholly transmitted to the storage unit 25 and stored, and the arithmetic unit 24 may be stored based on the stored information. May calculate the average value A3 of the frequency of heartbeats.
- the arithmetic unit 24 executes, for example, a computer program stored in the storage unit 25, and examples of the arithmetic unit constituting the arithmetic unit 24 include a central processing unit (CPU), a microprocessor (MPU), and the like. Examples of the storage device constituting the storage unit 25 include a RAM (RandomAccessMemory), a ROM (ReadOnlyMemory), and a flash memory.
- the biological information acquisition unit 10, the information processing unit 20, and the specific information generation unit 30 may be independently configured, or two or more units may be integrated.
- the biological information acquisition unit 10 may have a respiration measurement unit.
- the breathing measurement unit may be shared with the abdominal circumference measurement unit 41 or the chest circumference measurement unit 42. Further, each of these parts may be connected in a wired form, or each part may not be connected and may be in a form of transmitting and receiving signals wirelessly.
- the information processor preferably has a rectangular parallelepiped shape or a cubic shape, and more preferably a rectangular parallelepiped shape.
- the information processor is preferably small, and when it has a rectangular parallelepiped shape, the area of one main surface is preferably 3000 mm 2 or less, and more preferably 1500 mm 2 or less. Further, the area of one main surface may be 100 mm 2 or more, or 500 mm 2 or more.
- the thickness of the information processor is preferably 50 mm or less, more preferably 20 mm or less, and may be 2 mm or more, or 5 mm or more.
- FIG. 2 is a flowchart showing an example of a processing procedure performed by the asthma symptom management system 1.
- the biometric information acquisition unit 10 acquires biometric information (step S1).
- the arithmetic unit 24 calculates A1 and A2 and / or C1 and C2, and determines whether or not the equations (1) and / or the equation (2) are satisfied (step).
- step S2 the arithmetic unit 24 generates an instruction signal, and if the above equation is not satisfied, the arithmetic unit 24 does not generate an instruction signal (step S3).
- the specific information generation unit 30 that receives the command signal generates specific information (step S4). This makes it possible to notify the living body or a third party that a sign of an asthma attack or a mild asthma attack has occurred.
- the asthma symptom management system 2 may have an activity amount measuring unit 43 for measuring the activity amount of a living body.
- the activity amount measuring device constituting the activity amount measuring unit 43 include an accelerometer and the like.
- the amount of activity include an amount of activity expressed in acceleration or angular velocity, and acceleration is preferable. For details of acceleration and angular velocity, refer to the description in Japanese Patent Application Laid-Open No. 2019-047982.
- the biological information acquisition device constituting the biological information acquisition unit 10 and the information processing device constituting the information processing unit 20 may be fixed to the clothing, or may be detachably fixed to the clothing. It is preferable that the biometric information acquirer is fixed to clothing and the information processor is detachably fixed. Since the information processor is removable, it is possible to remove the information processor, which is easily damaged by washing, from the clothes and wash the clothes.
- the abdominal circumference measuring device, the chest circumference measuring device, and the activity amount measuring device are preferably fixed to clothing.
Abstract
Description
[1]生体の呼吸情報と心拍情報のうち少なくとも1つの生体情報を取得する生体情報取得部と、
下記式のうち少なくとも1つの式を満たした場合に特定情報S1を発生する特定情報発生部と、を有することを特徴とする喘息症状管理システム。
A1+B1≦A2≦A1+B2 ・・・(1)
[式中、A1は、第1の所定期間における呼吸および/または心拍の頻度の平均値であり、A2は、前記第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の頻度の平均値であり、B1は正の定数であり、B2はB1以上の正の定数である。但し、A1が呼吸の頻度の平均値であるときにはA2は呼吸の頻度の平均値であり、A1が心拍の頻度の平均値であるときにはA2は心拍の頻度の平均値である。]
C1-B4≦C2≦C1-B3 ・・・(2)
[式中、C1は、第1の所定期間における呼吸および/または心拍の間隔の平均値であり、C2は、前記第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の間隔の平均値であり、B3は正の定数であり、B4はB3以上の正の定数である。但し、C1が呼吸の間隔の平均値であるときにはC2は呼吸の間隔の平均値であり、C1が心拍の間隔の平均値であるときにはC2は心拍の間隔の平均値である。] The asthma symptom management system according to the embodiment of the present invention that has been able to solve the above problems is as follows.
[1] A biological information acquisition unit that acquires at least one biological information among the respiratory information and the heartbeat information of the living body,
An asthma symptom management system comprising a specific information generating unit that generates specific information S1 when at least one of the following equations is satisfied.
A1 + B1 ≤ A2 ≤ A1 + B2 ... (1)
[In the formula, A1 is the average value of the frequency of respiration and / or heartbeat in the first predetermined period, and A2 is the second starting point after 1 minute or more from the end point of the first predetermined period. Is the mean value of the frequency of respiration and / or heartbeat in a predetermined period, B1 is a positive constant, and B2 is a positive constant of B1 or more. However, when A1 is the average value of the frequency of respiration, A2 is the average value of the frequency of respiration, and when A1 is the average value of the frequency of heartbeat, A2 is the average value of the frequency of heartbeat. ]
C1-B4 ≤ C2 ≤ C1-B3 ... (2)
[In the formula, C1 is the average value of the breathing and / or heartbeat intervals in the first predetermined period, and C2 is the second starting point after 1 minute or more from the end point of the first predetermined period. Is the mean value of the breathing and / or heartbeat interval in the predetermined period, B3 is a positive constant, and B4 is a positive constant of B3 or more. However, when C1 is the mean value of the breathing interval, C2 is the mean value of the breathing interval, and when C1 is the mean value of the heartbeat interval, C2 is the mean value of the heartbeat interval. ]
[3]前記A1、A2が心拍の頻度の平均値であり、前記B1が10bpm~15bpmであり、前記B2が22bpm~30bpmである[1]または[2]に記載の喘息症状管理システム。
[4]前記特定情報S1は、前記生体情報の時間的周期が短くなったことを通知するものである[1]~[3]のいずれかに記載の喘息症状管理システム。
[5]下記式のうち少なくとも1つの式を満たす場合に、前記生体情報の時間的周期が長くなったことを通知するものである特定情報S2を発生する特定情報発生部を有する[1]~[4]のいずれかに記載の喘息症状管理システム。
A3<A2 ・・・(3)
[式中、A2は前記と同じ意味であり、A3は、前記第2の所定期間の終点以降の時点を始点とする第3の所定期間における呼吸および/または心拍の頻度の平均値である。但し、A2が呼吸の頻度の平均値であるときにはA3は呼吸の頻度の平均値であり、A2が心拍の頻度の平均値であるときにはA3は心拍の頻度の平均値である。]
C3>C2 ・・・(4)
[式中、C2は前記と同じ意味であり、C3は、前記第2の所定期間の終点以降の時点を始点とする第3の所定期間における呼吸および/または心拍の間隔の平均値である。但し、C2が呼吸の間隔の平均値であるときにはC3は呼吸の間隔の平均値であり、C2が心拍の間隔の平均値であるときにはC3は心拍の間隔の平均値である。]
[6]前記生体の腹部周囲長の変化を測定する腹部周囲長測定部を有し、
前記特定情報S2は、下記式(5)を満たす場合に発生するものである[5]に記載の喘息症状管理システム。
150≦平均腹部周囲長の変化率[(前記第2の所定期間における吸気時の平均腹部周囲長-前記第2の所定期間における呼気時の平均腹部周囲長)/(前記第3の所定期間における吸気時の平均腹部周囲長-前記第3の所定期間における呼気時の平均腹部周囲長)×100]・・・(5)
[7]前記生体の胸部平均周囲長の変化を測定する胸部周囲長測定部を有し、
前記特定情報S2は、下記式(6)を満たす場合に発生するものである[6]に記載の喘息症状管理システム。
前記平均腹部周囲長の変化率>平均胸部周囲長の変化率[(前記第2の所定期間における吸気時の平均胸部周囲長-前記第2の所定期間における呼気時の平均胸部周囲長)/(前記第3の所定期間における吸気時の平均胸部周囲長-前記第3の所定期間における呼気時の平均胸部周囲長)×100]・・・(6)
[8]前記A2が前記A1+B2以下である場合には前記特定情報S1を発生するように制御されており、前記A2が前記A1+B2超である場合には前記特定情報S1を発生しないように制御されている[1]~[7]のいずれかに記載の喘息症状管理システム。
[9]前記C2が前記C1-B4以上である場合には前記特定情報S1を発生するように制御されており、前記C2が前記C1-B4未満である場合には前記特定情報S1を発生しないように制御されている[1]~[8]のいずれかに記載の喘息症状管理システム。
[10]前記C1、C2が呼吸の間隔の平均値であり、前記B4が8秒~12秒であり、前記B3が3秒~6秒である[1]~[7]、[9]のいずれかに記載の喘息症状管理システム。
[11]前記C1、C2が心拍の間隔の平均値であり、前記B4が4000m秒~6000m秒であり、前記B3が2000m秒~2800m秒である[1]~[7]、[9]、[10]のいずれかに記載の喘息症状管理システム。
[12]前記特定情報発生部は、前記呼吸の頻度の平均値と前記心拍の頻度の平均値が前記式(1)を満たした場合に前記特定情報S1を発生する[1]~[8]のいずれかに記載の喘息症状管理システム。
[13]前記特定情報発生部は、前記呼吸の頻度の平均値と前記心拍の頻度の平均値が前記式(3)を満たした場合に前記特定情報S2を発生し、前記式(3)を満たさない場合には、前記特定情報S2を発生しないように制御されている[5]~[8]のいずれかに記載の喘息症状管理システム。
[14]前記特定情報発生部は、前記呼吸の間隔の平均値と前記心拍の間隔の平均値が前記式(2)を満たした場合に前記特定情報S1を発生する[1]、[4]~[7]、[9]~[11]のいずれかに記載の喘息症状管理システム。
[15]前記特定情報発生部は、前記呼吸の間隔の平均値と前記心拍の間隔の平均値が前記式(4)を満たした場合に前記特定情報S2を発生し、前記式(4)を満たさない場合には、前記特定情報S2を発生しないように制御されている[5]~[7]、[9]~[11]、[14]のいずれかに記載の喘息症状管理システム。
[16]前記特定情報発生部は、前記平均腹部周囲長の変化率が式(5)を満たさない場合には、前記特定情報S2を発生しないように制御されている[5]~[15]のいずれかに記載の喘息症状管理システム。
[17]前記特定情報発生部は、前記平均腹部周囲長の変化率が式(6)を満たさない場合には、前記特定情報S2を発生しないように制御されている[5]~[16]のいずれかに記載の喘息症状管理システム。
[18]更に、前記生体情報取得部から得られた生体情報を受信する情報受信部を有する[1]~[17]のいずれかに記載の喘息症状管理システム。
[19]更に、前記式の算出を行う演算部を含む[1]~[18]のいずれかに記載の喘息症状管理システム。
[20]更に、前記生体情報および/または前記平均値を記憶する記憶部を含む[1]~[19]のいずれかに記載の喘息症状管理システム。
[21]更に、前記演算部から得られた情報を前記特定情報発生部へ送信する信号送信部を含む[1]~[20]のいずれかに記載の喘息症状管理システム。
[22]前記情報受信部、前記演算部、及び前記記憶部を含む情報処理器を備える[20]または[21]に記載の喘息症状管理システム。
[23]前記情報処理器は、更に前記信号送信部を含む[22]に記載の喘息症状管理システム。
[24]前記生体情報取得部を含む生体情報取得器を備え、前記生体情報取得器は、前記情報処理器に連結されている[22]または[23]に記載の喘息症状管理システム。
[25]無線で信号を受信可能な信号受信部と、前記特定情報発生部とを含む特定情報発生器を備え、前記特定情報発生器は、前記情報処理器に連結されていない[22]~[24]のいずれかに記載の喘息症状管理システム。
[26]有線で信号を受信可能な信号受信部と、前記特定情報発生部とを含む特定情報発生器を備え、前記特定情報発生器は、前記情報処理器に連結されている[22]~[24]のいずれかに記載の喘息症状管理システム。
[27]前記腹部周囲長測定部を含む腹部周囲長測定器を備え、前記腹部周囲長測定器は、前記情報処理器に連結されている[22]~[26]のいずれかに記載の喘息症状管理システム。
[28]前記胸部周囲長測定部を含む胸部周囲長測定器を備え、前記胸部周囲長測定器は、前記情報処理器に連結されている[22]~[27]のいずれかに記載の喘息症状管理システム。
[29][1]~[28]のいずれかに記載の喘息症状管理システムを備える衣類。 [2] The asthma symptom management system according to [1], wherein A1 and A2 are average values of respiratory frequency, B1 is 5 cpm to 7 cpm, and B2 is 10 cpm to 20 cpm.
[3] The asthma symptom management system according to [1] or [2], wherein A1 and A2 are average values of heartbeat frequencies, B1 is 10 bpm to 15 bpm, and B2 is 22 bpm to 30 bpm.
[4] The asthma symptom management system according to any one of [1] to [3], wherein the specific information S1 notifies that the time cycle of the biological information has been shortened.
[5] The present invention has a specific information generating unit that generates specific information S2 that notifies that the time cycle of the biometric information has become longer when at least one of the following equations is satisfied [1] to. The asthma symptom management system according to any one of [4].
A3 <A2 ... (3)
[In the formula, A2 has the same meaning as described above, and A3 is the average value of the frequency of respiration and / or heartbeat in the third predetermined period starting from the time point after the end point of the second predetermined period. However, when A2 is the mean value of the breathing frequency, A3 is the mean value of the breathing frequency, and when A2 is the mean value of the heartbeat frequency, A3 is the mean value of the heartbeat frequency. ]
C3> C2 ... (4)
[In the formula, C2 has the same meaning as described above, and C3 is the average value of the breathing and / or heartbeat intervals in the third predetermined period starting from the time point after the end point of the second predetermined period. However, when C2 is the mean value of the breathing interval, C3 is the mean value of the breathing interval, and when C2 is the mean value of the heartbeat interval, C3 is the mean value of the heartbeat interval. ]
[6] It has an abdominal circumference measuring unit for measuring a change in the abdominal circumference of the living body.
The asthma symptom management system according to [5], wherein the specific information S2 is generated when the following formula (5) is satisfied.
150 ≤ rate of change in average abdominal circumference [(average abdominal circumference during inspiration during the second predetermined period-average abdominal circumference during expiration during the second predetermined period) / (in the third predetermined period) Average abdominal circumference at the time of inspiration-Average abdominal circumference at the time of exhalation in the third predetermined period) × 100] ... (5)
[7] It has a chest circumference measuring unit for measuring a change in the average chest circumference of the living body.
The asthma symptom management system according to [6], wherein the specific information S2 is generated when the following formula (6) is satisfied.
Rate of change in average abdominal circumference> Rate of change in average chest circumference [(Average chest circumference during inspiration during the second predetermined period-Average chest circumference during exhalation during the second predetermined period) / ( Average chest circumference during inspiration during the third predetermined period-Average chest circumference during exhalation during the third predetermined period) x 100] ... (6)
[8] When the A2 is A1 + B2 or less, the specific information S1 is controlled to be generated, and when the A2 is more than the A1 + B2, the specific information S1 is not generated. The asthma symptom management system according to any one of [1] to [7].
[9] When the C2 is C1-B4 or more, the specific information S1 is controlled to be generated, and when the C2 is less than the C1-B4, the specific information S1 is not generated. The asthma symptom management system according to any one of [1] to [8], which is controlled in such a manner.
[10] C1 and C2 are average values of breathing intervals, B4 is 8 to 12 seconds, and B3 is 3 to 6 seconds [1] to [7] and [9]. Asthma symptom management system described in any.
[11] C1 and C2 are average values of heartbeat intervals, B4 is 4000 msec to 6000 msec, and B3 is 2000 msec to 2800 msec [1] to [7], [9], The asthma symptom management system according to any one of [10].
[12] The specific information generation unit generates the specific information S1 when the average value of the frequency of respiration and the average value of the frequency of heartbeat satisfy the equation (1) [1] to [8]. Asthma symptom management system described in any of.
[13] The specific information generating unit generates the specific information S2 when the average value of the frequency of respiration and the average value of the frequency of the heartbeat satisfy the equation (3), and the equation (3) is expressed. The asthma symptom management system according to any one of [5] to [8], which is controlled so as not to generate the specific information S2 when the specific information S2 is not satisfied.
[14] The specific information generating unit generates the specific information S1 when the average value of the breathing interval and the average value of the heartbeat interval satisfy the equation (2) [1], [4]. The asthma symptom management system according to any one of [7] and [9] to [11].
[15] The specific information generating unit generates the specific information S2 when the average value of the breathing interval and the average value of the heartbeat interval satisfy the equation (4), and the equation (4) is expressed. The asthma symptom management system according to any one of [5] to [7], [9] to [11], and [14], which is controlled so as not to generate the specific information S2 when the specific information S2 is not satisfied.
[16] The specific information generating unit is controlled so as not to generate the specific information S2 when the rate of change of the average abdominal circumference does not satisfy the equation (5) [5] to [15]. Asthma symptom management system described in any of.
[17] The specific information generating unit is controlled so as not to generate the specific information S2 when the rate of change of the average abdominal circumference does not satisfy the equation (6) [5] to [16]. Asthma symptom management system described in any of.
[18] The asthma symptom management system according to any one of [1] to [17], further comprising an information receiving unit for receiving biometric information obtained from the biometric information acquisition unit.
[19] The asthma symptom management system according to any one of [1] to [18], further comprising a calculation unit for calculating the above equation.
[20] The asthma symptom management system according to any one of [1] to [19], further comprising a storage unit that stores the biological information and / or the average value.
[21] The asthma symptom management system according to any one of [1] to [20], further comprising a signal transmission unit that transmits information obtained from the calculation unit to the specific information generation unit.
[22] The asthma symptom management system according to [20] or [21], comprising an information processing device including the information receiving unit, the arithmetic unit, and the storage unit.
[23] The asthma symptom management system according to [22], wherein the information processor further includes the signal transmission unit.
[24] The asthma symptom management system according to [22] or [23], which includes a biometric information acquirer including the biometric information acquisition unit, wherein the biometric information acquirer is connected to the information processor.
[25] A specific information generator including a signal receiving unit capable of receiving a signal wirelessly and the specific information generating unit is provided, and the specific information generator is not connected to the information processing device [22] to The asthma symptom management system according to any one of [24].
[26] A specific information generator including a signal receiving unit capable of receiving a signal by wire and the specific information generating unit is provided, and the specific information generator is connected to the information processing device [22] to The asthma symptom management system according to any one of [24].
[27] The asthma according to any one of [22] to [26], wherein the abdominal circumference measuring device including the abdominal circumference measuring section is provided, and the abdominal circumference measuring device is connected to the information processing device. Symptom management system.
[28] The asthma according to any one of [22] to [27], which comprises a chest circumference measuring device including the chest circumference measuring section, and the chest circumference measuring device is connected to the information processing device. Symptom management system.
[29] Clothing provided with the asthma symptom management system according to any one of [1] to [28].
A1+B1≦A2≦A1+B2 ・・・(1)
[式中、A1は、第1の所定期間における呼吸および/または心拍の頻度の平均値であり、A2は、第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の頻度の平均値であり、B1は正の定数であり、B2はB1以上の正の定数である。但し、A1が呼吸の頻度の平均値であるときにはA2は呼吸の頻度の平均値であり、A1が心拍の頻度の平均値であるときにはA2は心拍の頻度の平均値である。]
C1-B4≦C2≦C1-B3 ・・・(2)
[式中、C1は、第1の所定期間における呼吸および/または心拍の間隔の平均値であり、C2は、第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の間隔の平均値であり、B3は正の定数であり、B4はB3以上の正の定数である。但し、C1が呼吸の間隔の平均値であるときにはC2は呼吸の間隔の平均値であり、C1が心拍の間隔の平均値であるときにはC2は心拍の間隔の平均値である。] The asthma symptom management system according to the embodiment of the present invention satisfies the biological information acquisition unit that acquires at least one of the respiratory information and the heartbeat information of the living body, and at least one of the following equations. It has a specific information generation unit that generates specific information S1.
A1 + B1 ≤ A2 ≤ A1 + B2 ... (1)
[In the formula, A1 is the average value of the frequency of respiration and / or heartbeat in the first predetermined period, and A2 is the second starting point after 1 minute or more from the end point of the first predetermined period. It is the mean value of the frequency of respiration and / or heartbeat in a predetermined period, B1 is a positive constant, and B2 is a positive constant of B1 or more. However, when A1 is the average value of the frequency of respiration, A2 is the average value of the frequency of respiration, and when A1 is the average value of the frequency of heartbeat, A2 is the average value of the frequency of heartbeat. ]
C1-B4 ≤ C2 ≤ C1-B3 ... (2)
[In the formula, C1 is the average value of the breathing and / or heartbeat intervals in the first predetermined period, and C2 is the second starting point starting from a time point one minute or more after the end point of the first predetermined period. It is the mean value of the interval between breathing and / or heartbeat in a predetermined period, B3 is a positive constant, and B4 is a positive constant of B3 or more. However, when C1 is the mean value of the breathing interval, C2 is the mean value of the breathing interval, and when C1 is the mean value of the heartbeat interval, C2 is the mean value of the heartbeat interval. ]
A1+B1≦A2≦A1+B2 ・・・(1)
[式中、A1は、第1の所定期間における呼吸および/または心拍の頻度の平均値であり、A2は、第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の頻度の平均値であり、B1は正の定数であり、B2はB1以上の正の定数である。但し、A1が呼吸の頻度の平均値であるときにはA2は呼吸の頻度の平均値であり、A1が心拍の頻度の平均値であるときにはA2は心拍の頻度の平均値である。]
C1-B4≦C2≦C1-B3 ・・・(2)
[式中、C1は、第1の所定期間における呼吸および/または心拍の間隔の平均値であり、C2は、第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の間隔の平均値であり、B3は正の定数であり、B4はB3以上の正の定数である。但し、C1が呼吸の間隔の平均値であるときにはC2は呼吸の間隔の平均値であり、C1が心拍の間隔の平均値であるときにはC2は心拍の間隔の平均値である。] The specific
A1 + B1 ≤ A2 ≤ A1 + B2 ... (1)
[In the formula, A1 is the average value of the frequency of respiration and / or heartbeat in the first predetermined period, and A2 is the second starting point after 1 minute or more from the end point of the first predetermined period. It is the mean value of the frequency of respiration and / or heartbeat in a predetermined period, B1 is a positive constant, and B2 is a positive constant of B1 or more. However, when A1 is the average value of the frequency of respiration, A2 is the average value of the frequency of respiration, and when A1 is the average value of the frequency of heartbeat, A2 is the average value of the frequency of heartbeat. ]
C1-B4 ≤ C2 ≤ C1-B3 ... (2)
[In the formula, C1 is the average value of the breathing and / or heartbeat intervals in the first predetermined period, and C2 is the second starting point starting from a time point one minute or more after the end point of the first predetermined period. It is the mean value of the interval between breathing and / or heartbeat in a predetermined period, B3 is a positive constant, and B4 is a positive constant of B3 or more. However, when C1 is the mean value of the breathing interval, C2 is the mean value of the breathing interval, and when C1 is the mean value of the heartbeat interval, C2 is the mean value of the heartbeat interval. ]
A3<A2 ・・・(3)
[式中、A2は上記と同じ意味であり、A3は、第2の所定期間の終点以降の時点を始点とする第3の所定期間における呼吸および/または心拍の頻度の平均値である。但し、A2が呼吸の頻度の平均値であるときにはA3は呼吸の頻度の平均値であり、A2が心拍の頻度の平均値であるときにはA3は心拍の頻度の平均値である。]
C3>C2 ・・・(4)
[式中、C2は上記と同じ意味であり、C3は、第2の所定期間の終点以降の時点を始点とする第3の所定期間における呼吸および/または心拍の間隔の平均値である。但し、C2が呼吸の間隔の平均値であるときにはC3は呼吸の間隔の平均値であり、C2が心拍の間隔の平均値であるときにはC3は心拍の間隔の平均値である。] The asthma symptom management system 1 has a specific information generation unit that generates specific information S2 that notifies that the time cycle of biological information has become longer when at least one of the following equations is satisfied. Is preferable.
A3 <A2 ... (3)
[In the formula, A2 has the same meaning as described above, and A3 is the average value of the frequency of respiration and / or heartbeat in the third predetermined period starting from the time point after the end point of the second predetermined period. However, when A2 is the mean value of the breathing frequency, A3 is the mean value of the breathing frequency, and when A2 is the mean value of the heartbeat frequency, A3 is the mean value of the heartbeat frequency. ]
C3> C2 ... (4)
[In the formula, C2 has the same meaning as described above, and C3 is the average value of the breathing and / or heartbeat intervals in the third predetermined period starting from the time point after the end point of the second predetermined period. However, when C2 is the mean value of the breathing interval, C3 is the mean value of the breathing interval, and when C2 is the mean value of the heartbeat interval, C3 is the mean value of the heartbeat interval. ]
150≦平均腹部周囲長の変化率[(第2の所定期間における吸気時の平均腹部周囲長-第2の所定期間における呼気時の平均腹部周囲長)/(第3の所定期間における吸気時の平均腹部周囲長-第3の所定期間における呼気時の平均腹部周囲長)×100]・・・(5) It is preferable that the asthma symptom management system 1 has an abdominal
150 ≤ Average abdominal circumference change rate [(Average abdominal circumference during inspiration in the second predetermined period-Average abdominal circumference during expiration in the second predetermined period) / (Inhalation in the third predetermined period) Average abdominal circumference-Average abdominal circumference at the time of exhalation in the third predetermined period) x 100] ... (5)
上記平均腹部周囲長の変化率>平均胸部周囲長の変化率[(第2の所定期間における吸気時の平均胸部周囲長-第2の所定期間における呼気時の平均胸部周囲長)/(第3の所定期間における吸気時の平均胸部周囲長-第3の所定期間における呼気時の平均胸部周囲長)×100]・・・(6) It is preferable that the asthma symptom management system 1 has a chest
Rate of change in average abdominal circumference> Rate of change in average chest circumference [(Average chest circumference during inspiration in the second predetermined period-Average chest circumference during exhalation in the second predetermined period) / (3rd Average chest circumference during inspiration during the predetermined period-Average chest circumference during exhalation during the third predetermined period) x 100] ... (6)
2 喘息症状管理システム
10 生体情報取得部
20 情報処理部
21 情報受信部
22 不良情報判定部
23 不良情報除去部
24 演算部
25 記憶部
26 信号送信部
30 特定情報発生部
31 信号受信部
32 特定情報知覚化部
41 腹部周囲長測定部
42 胸部周囲長測定部
43 活動量測定部 1 Asthma
Claims (10)
- 生体の呼吸情報と心拍情報のうち少なくとも1つの生体情報を取得する生体情報取得部と、
下記式のうち少なくとも1つの式を満たした場合に特定情報S1を発生する特定情報発生部と、を有することを特徴とする喘息症状管理システム。
A1+B1≦A2≦A1+B2 ・・・(1)
[式中、A1は、第1の所定期間における呼吸および/または心拍の頻度の平均値であり、A2は、前記第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の頻度の平均値であり、B1は正の定数であり、B2はB1以上の正の定数である。但し、A1が呼吸の頻度の平均値であるときにはA2は呼吸の頻度の平均値であり、A1が心拍の頻度の平均値であるときにはA2は心拍の頻度の平均値である。]
C1-B4≦C2≦C1-B3 ・・・(2)
[式中、C1は、第1の所定期間における呼吸および/または心拍の間隔の平均値であり、C2は、前記第1の所定期間の終点から1分以上後の時点を始点とする第2の所定期間における呼吸および/または心拍の間隔の平均値であり、B3は正の定数であり、B4はB3以上の正の定数である。但し、C1が呼吸の間隔の平均値であるときにはC2は呼吸の間隔の平均値であり、C1が心拍の間隔の平均値であるときにはC2は心拍の間隔の平均値である。] A biological information acquisition unit that acquires at least one biological information among the respiratory information and the heartbeat information of the living body,
An asthma symptom management system comprising a specific information generating unit that generates specific information S1 when at least one of the following equations is satisfied.
A1 + B1 ≤ A2 ≤ A1 + B2 ... (1)
[In the formula, A1 is the average value of the frequency of respiration and / or heartbeat in the first predetermined period, and A2 is the second starting point after 1 minute or more from the end point of the first predetermined period. Is the mean value of the frequency of respiration and / or heartbeat in a predetermined period, B1 is a positive constant, and B2 is a positive constant of B1 or more. However, when A1 is the average value of the frequency of respiration, A2 is the average value of the frequency of respiration, and when A1 is the average value of the frequency of heartbeat, A2 is the average value of the frequency of heartbeat. ]
C1-B4 ≤ C2 ≤ C1-B3 ... (2)
[In the formula, C1 is the average value of the breathing and / or heartbeat intervals in the first predetermined period, and C2 is the second starting point after 1 minute or more from the end point of the first predetermined period. Is the mean value of the breathing and / or heartbeat interval in the predetermined period, B3 is a positive constant, and B4 is a positive constant of B3 or more. However, when C1 is the mean value of the breathing interval, C2 is the mean value of the breathing interval, and when C1 is the mean value of the heartbeat interval, C2 is the mean value of the heartbeat interval. ] - 前記A1、A2が呼吸の頻度の平均値であり、前記B1が5cpm~7cpmであり、前記B2が10cpm~20cpmである請求項1に記載の喘息症状管理システム。 The asthma symptom management system according to claim 1, wherein A1 and A2 are average values of respiratory frequency, B1 is 5 cpm to 7 cpm, and B2 is 10 cpm to 20 cpm.
- 前記A1、A2が心拍の頻度の平均値であり、前記B1が10bpm~15bpmであり、前記B2が22bpm~30bpmである請求項1または2に記載の喘息症状管理システム。 The asthma symptom management system according to claim 1 or 2, wherein A1 and A2 are average values of heartbeat frequencies, B1 is 10 bpm to 15 bpm, and B2 is 22 bpm to 30 bpm.
- 前記特定情報S1は、前記生体情報の時間的周期が短くなったことを通知するものである請求項1~3のいずれかに記載の喘息症状管理システム。 The asthma symptom management system according to any one of claims 1 to 3, wherein the specific information S1 notifies that the time cycle of the biological information has become shorter.
- 下記式のうち少なくとも1つの式を満たす場合に、前記生体情報の時間的周期が長くなったことを通知するものである特定情報S2を発生する特定情報発生部を有する請求項1~4のいずれかに記載の喘息症状管理システム。
A3<A2 ・・・(3)
[式中、A2は前記と同じ意味であり、A3は、前記第2の所定期間の終点以降の時点を始点とする第3の所定期間における呼吸および/または心拍の頻度の平均値である。但し、A2が呼吸の頻度の平均値であるときにはA3は呼吸の頻度の平均値であり、A2が心拍の頻度の平均値であるときにはA3は心拍の頻度の平均値である。]
C3>C2 ・・・(4)
[式中、C2は前記と同じ意味であり、C3は、前記第2の所定期間の終点以降の時点を始点とする第3の所定期間における呼吸および/または心拍の間隔の平均値である。但し、C2が呼吸の間隔の平均値であるときにはC3は呼吸の間隔の平均値であり、C2が心拍の間隔の平均値であるときにはC3は心拍の間隔の平均値である。] Any of claims 1 to 4 having a specific information generating unit that generates specific information S2 that notifies that the time cycle of the biometric information has become longer when at least one of the following equations is satisfied. Asthma symptom management system described in Crab.
A3 <A2 ... (3)
[In the formula, A2 has the same meaning as described above, and A3 is the average value of the frequency of respiration and / or heartbeat in the third predetermined period starting from the time point after the end point of the second predetermined period. However, when A2 is the mean value of the breathing frequency, A3 is the mean value of the breathing frequency, and when A2 is the mean value of the heartbeat frequency, A3 is the mean value of the heartbeat frequency. ]
C3> C2 ... (4)
[In the formula, C2 has the same meaning as described above, and C3 is the average value of the breathing and / or heartbeat intervals in the third predetermined period starting from the time point after the end point of the second predetermined period. However, when C2 is the mean value of the breathing interval, C3 is the mean value of the breathing interval, and when C2 is the mean value of the heartbeat interval, C3 is the mean value of the heartbeat interval. ] - 前記生体の腹部周囲長の変化を測定する腹部周囲長測定部を有し、
前記特定情報S2は、下記式(5)を満たす場合に発生するものである請求項5に記載の喘息症状管理システム。
150≦平均腹部周囲長の変化率[(前記第2の所定期間における吸気時の平均腹部周囲長-前記第2の所定期間における呼気時の平均腹部周囲長)/(前記第3の所定期間における吸気時の平均腹部周囲長-前記第3の所定期間における呼気時の平均腹部周囲長)×100]・・・(5) It has an abdominal circumference measuring unit that measures changes in the abdominal circumference of the living body.
The asthma symptom management system according to claim 5, wherein the specific information S2 is generated when the following formula (5) is satisfied.
150 ≤ rate of change in average abdominal circumference [(average abdominal circumference during inspiration during the second predetermined period-average abdominal circumference during expiration during the second predetermined period) / (in the third predetermined period) Average abdominal circumference at the time of inspiration-Average abdominal circumference at the time of exhalation in the third predetermined period) × 100] ... (5) - 前記生体の胸部平均周囲長の変化を測定する胸部周囲長測定部を有し、
前記特定情報S2は、下記式(6)を満たす場合に発生するものである請求項6に記載の喘息症状管理システム。
前記平均腹部周囲長の変化率>平均胸部周囲長の変化率[(前記第2の所定期間における吸気時の平均胸部周囲長-前記第2の所定期間における呼気時の平均胸部周囲長)/(前記第3の所定期間における吸気時の平均胸部周囲長-前記第3の所定期間における呼気時の平均胸部周囲長)×100]・・・(6) It has a chest circumference measuring unit that measures changes in the average chest circumference of the living body.
The asthma symptom management system according to claim 6, wherein the specific information S2 is generated when the following formula (6) is satisfied.
Rate of change in average abdominal circumference> Rate of change in average chest circumference [(Average chest circumference during inspiration during the second predetermined period-Average chest circumference during exhalation during the second predetermined period) / ( Average chest circumference during inspiration during the third predetermined period-Average chest circumference during exhalation during the third predetermined period) x 100] ... (6) - 前記A2が前記A1+B2以下である場合には前記特定情報S1を発生するように制御されており、前記A2が前記A1+B2超である場合には前記特定情報S1を発生しないように制御されている請求項1~7のいずれかに記載の喘息症状管理システム。 A claim that is controlled to generate the specific information S1 when the A2 is equal to or less than the A1 + B2, and is controlled not to generate the specific information S1 when the A2 is greater than the A1 + B2. The asthma symptom management system according to any one of Items 1 to 7.
- 前記C2が前記C1-B4以上である場合には前記特定情報S1を発生するように制御されており、前記C2が前記C1-B4未満である場合には前記特定情報S1を発生しないように制御されている請求項1~8のいずれかに記載の喘息症状管理システム。 When the C2 is C1-B4 or more, the specific information S1 is controlled to be generated, and when the C2 is less than the C1-B4, the specific information S1 is not generated. The asthma symptom management system according to any one of claims 1 to 8.
- 請求項1~9のいずれかに記載の喘息症状管理システムを備える衣類。 Clothing provided with the asthma symptom management system according to any one of claims 1 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022555374A JPWO2022075105A1 (en) | 2020-10-05 | 2021-09-27 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020168571 | 2020-10-05 | ||
JP2020-168571 | 2020-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022075105A1 true WO2022075105A1 (en) | 2022-04-14 |
Family
ID=81126765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/035321 WO2022075105A1 (en) | 2020-10-05 | 2021-09-27 | Asthma symptom management system and clothing provided with asthma symptom management system |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2022075105A1 (en) |
WO (1) | WO2022075105A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59177070A (en) * | 1983-03-29 | 1984-10-06 | 三菱電機株式会社 | Abdominal breathing exerciser |
JP2009501557A (en) * | 2005-06-21 | 2009-01-22 | アーリーセンス エルティディ | Clinical symptom prediction and monitoring technology |
JP2011104102A (en) * | 2009-11-17 | 2011-06-02 | Mansankai | Hrv change detecting method for health decision and hrv change detector for health decision |
JP2012085906A (en) * | 2010-10-21 | 2012-05-10 | Sharp Corp | Device for monitoring living body, method for monitoring living body, system for monitoring living body, control program, and recording medium on which the control program is recorded |
KR20160106958A (en) * | 2015-03-03 | 2016-09-13 | 이승환 | Apparatus and method for monitoring an asthma |
US20170258366A1 (en) * | 2009-03-30 | 2017-09-14 | Joe P. Tupin, JR. | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
-
2021
- 2021-09-27 JP JP2022555374A patent/JPWO2022075105A1/ja active Pending
- 2021-09-27 WO PCT/JP2021/035321 patent/WO2022075105A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59177070A (en) * | 1983-03-29 | 1984-10-06 | 三菱電機株式会社 | Abdominal breathing exerciser |
JP2009501557A (en) * | 2005-06-21 | 2009-01-22 | アーリーセンス エルティディ | Clinical symptom prediction and monitoring technology |
US20170258366A1 (en) * | 2009-03-30 | 2017-09-14 | Joe P. Tupin, JR. | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
JP2011104102A (en) * | 2009-11-17 | 2011-06-02 | Mansankai | Hrv change detecting method for health decision and hrv change detector for health decision |
JP2012085906A (en) * | 2010-10-21 | 2012-05-10 | Sharp Corp | Device for monitoring living body, method for monitoring living body, system for monitoring living body, control program, and recording medium on which the control program is recorded |
KR20160106958A (en) * | 2015-03-03 | 2016-09-13 | 이승환 | Apparatus and method for monitoring an asthma |
Also Published As
Publication number | Publication date |
---|---|
JPWO2022075105A1 (en) | 2022-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Matar et al. | Unobtrusive sleep monitoring using cardiac, breathing and movements activities: an exhaustive review | |
CN108042108B (en) | Sleep quality monitoring method and system based on body vibration signals | |
US11224385B2 (en) | Method for determining a person's sleeping phase which is favourable for waking up | |
JP6455843B2 (en) | Device for monitoring and processing physiological values and method of operation thereof | |
JP5841716B2 (en) | Method and system for interpreting and analyzing physiological information, performance information and situation information | |
JP5174348B2 (en) | Method and apparatus for monitoring heart related condition parameters | |
US10213153B2 (en) | Wearable pain monitor using accelerometry | |
JP6203468B2 (en) | Multi-mode method and system for transmitting information about a subject | |
Fekr et al. | Design and evaluation of an intelligent remote tidal volume variability monitoring system in e-health applications | |
Takano et al. | Noncontact in-bed measurements of physiological and behavioral signals using an integrated fabric-sheet sensing scheme | |
US20150208949A1 (en) | Apparatus and method for continuous noninvasive measurement of respiratory function and events | |
EP3187116B1 (en) | Method for assessing depressive state and device for assessing depressive state | |
KR20080034437A (en) | Techniques for prediction and monitoring of clinical episodes | |
US10123724B2 (en) | Breath volume monitoring system and method | |
Yüzer et al. | A novel wearable real-time sleep apnea detection system based on the acceleration sensor | |
CA3067778C (en) | Non-contact heart rate monitoring | |
JP6521345B1 (en) | Measuring belt | |
CA3100475C (en) | Apparatus and a method for monitoring a patient during his sleep | |
WO2022075105A1 (en) | Asthma symptom management system and clothing provided with asthma symptom management system | |
JP6714352B2 (en) | Biometric information management system | |
JP2017080141A (en) | Respiration analysis device, respiration analysis method, and program | |
JP6506480B2 (en) | Device for monitoring food and / or drink intake by a subject | |
Nakasho et al. | Implementation of a vital signs monitoring system in combination with a bed-leaving detection system | |
JP2016116727A (en) | Biological information management system | |
RU106831U1 (en) | DEVICE FOR REMOTE HUMAN RESPIRATORY SYSTEM MONITORING |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21877406 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022555374 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 07/07/2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21877406 Country of ref document: EP Kind code of ref document: A1 |